Primary results of the Phase Ib proof-of-concept study of NI006, a recombinant human antibody to deplete amyloid deposits in ATTR-cardiomyopathy
20 May 2023 (16:40 - 16:50)
Organised by: 
Slides
About the speaker
Hospital Universitario Puerta de Hierro Majadahonda, Majadahonda (Spain)
5 More presentations in this session
Professor W. Tang (Cleveland, US)
Professor J. Januzzi (Boston, US)
Professor M. Fontana (London, GB)
Access the full session
The Event
Heart Failure 2023
20 May 2023
16:40 CET
You may be interested in
Congress Session
